Clinical Trials
4 trialsNCT05006196 2026-05-20
IMOGEN
Perspectum
Active not recruiting
NCT05755269 2026-05-01
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
Mayo Clinic
Terminated
NCT05876728 2023-05-25
Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer
Sohag University
Unknown
NCT00580021 2016-01-28
Clinical Outcomes in Hereditary Cancer
Memorial Sloan Kettering Cancer Center
Withdrawn